Collagen	0	8	B-Gene_or_gene_product
-	8	9	O
poly	9	13	B-Drug_or_compound
glycolic	14	22	I-Drug_or_compound
acid	23	27	I-Drug_or_compound
hybrid	28	34	O
matrix	35	41	O
with	42	46	O
basic	47	52	B-Gene_or_gene_product
fibroblast	53	63	I-Gene_or_gene_product
growth	64	70	I-Gene_or_gene_product
factor	71	77	I-Gene_or_gene_product
accelerated	78	89	O
angiogenesis	90	102	O
and	103	106	O
granulation	107	118	B-Tissue
tissue	119	125	I-Tissue
formation	126	135	O
in	136	138	O
diabetic	139	147	O
mice	148	152	B-Organism
.	152	153	O

Because	155	162	O
poor	163	167	O
skin	168	172	B-Organ
wound	173	178	O
healing	179	186	O
associated	187	197	O
with	198	202	O
diabetes	203	211	O
is	212	214	O
thought	215	222	O
to	223	225	O
be	226	228	O
partly	229	235	O
a	236	237	O
result	238	244	O
from	245	249	O
impaired	250	258	O
angiogenesis	259	271	O
,	271	272	O
treatments	273	283	O
that	284	288	O
improve	289	296	O
angiogenesis	297	309	O
could	310	315	O
have	316	320	O
important	321	330	O
clinical	331	339	O
applications	340	352	O
.	352	353	O

We	354	356	O
herein	357	363	O
report	364	370	O
the	371	374	O
effects	375	382	O
of	383	385	O
novel	386	391	O
developed	392	401	O
material	402	410	O
,	410	411	O
collagen	412	420	B-Gene_or_gene_product
-	420	421	O
poly	421	425	B-Drug_or_compound
glycolic	426	434	I-Drug_or_compound
acid	435	439	I-Drug_or_compound
fiber	440	445	O
hybrid	446	452	O
matrix	453	459	O
,	459	460	O
being	461	466	O
used	467	471	O
together	472	480	O
with	481	485	O
basic	486	491	B-Gene_or_gene_product
fibroblast	492	502	I-Gene_or_gene_product
growth	503	509	I-Gene_or_gene_product
factor	510	516	I-Gene_or_gene_product
to	517	519	O
promote	520	527	O
wound	528	533	O
healing	534	541	O
of	542	544	O
full	545	549	O
-	549	550	O
thickness	550	559	O
skin	560	564	B-Organ
defects	565	572	O
on	573	575	O
the	576	579	O
back	580	584	O
of	585	587	O
type	588	592	O
2	593	594	O
diabetic	595	603	O
Lepr	604	608	B-Gene_or_gene_product
(	608	609	O
db	609	611	O
)	611	612	O
mice	613	617	O
.	617	618	O

Our	619	622	O
data	623	627	O
indicates	628	637	O
that	638	642	O
this	643	647	O
therapeutic	648	659	O
approach	660	668	O
markedly	669	677	O
promotes	678	686	O
angiogenesis	687	699	O
and	700	703	O
granulation	704	715	B-Tissue
tissue	716	722	I-Tissue
formation	723	732	O
in	733	735	O
comparison	736	746	O
with	747	751	O
other	752	757	O
conditions	758	768	O
14	769	771	O
days	772	776	O
after	777	782	O
wounding	783	791	O
.	791	792	O

